![Keld Flintholm Jørgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keld Flintholm Jørgensen
Plus aucun poste en cours
Profil
Keld Flintholm Jørgensen formerly worked at Roche Pharma (Schweiz) AG, as Director-Strategic Partnering, Scandion Oncology A, as Independent Director, and H.
Lundbeck A, as Senior VP & Head-Business Development in 2024.
Mr. Jørgensen received his undergraduate degree and graduate degree from Copenhagen Business School.
Anciens postes connus de Keld Flintholm Jørgensen
| Sociétés | Poste | Fin |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 01/12/2024 |
| SCANDION ONCOLOGY A/S | Directeur/Membre du Conseil | - |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Formation de Keld Flintholm Jørgensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
